‘Dormant’ biotech wakes on Alzheimer’s fast track
By GREGORY ZELLER // A pre-clinical-stage biopharmaceutical company is being fast-tracked toward a potential Alzheimer’s treatment, after taking a decidedly slow road. Stony Brook-based Avanti Biosciences Inc. actually launched in…